News

Photo

Corteva Buys Spanish Microbiological Expert

US agricultural company Corteva, which combines businesses formerly belonging to DuPont, Dow and Pioneer, has agreed to buy Symborg, an expert in microbiological technologies based in Murcia, Spain. Financial terms were not disclosed.

Photo

Arkema Joins PET Recycling Project

French chemicals and materials company Arkema is participating in a Spanish consortium to explore and advance the recyclability of post-consumer polyester resin (PET from bottles and other items) in order to regain monomers for use in more sustainable powder coatings.

Photo

New Specialty Life Science Player Actylis Debuts

US specialty materials manufacturer Aceto and 10 other companies with business operations in North America, Europe, India and China have merged into a new cross-industry player called Actylis, under the umbrella of private equity investor New Mountain Capital.

Photo

Unilever Chief to Quit sooner after failed GSK Bid

British-multinational consumer products giant Unilever has announced that its chief executive, Alan Jope, will retire at the end of 2023. The potentially earlier than planned departure announcement had been anticipated.

Photo

Bloomberg Funds Program to Block US Petchem Projects

Michael Bloomberg, the founder of US-based financial, software, data and media group Bloomberg LP and a United Nations special envoy on climate ambition and solutions, has launched a campaign to stop the expansion of petrochemicals and plastics production in the US.

Photo

Consortium Plans Carbon Capture in Singapore

Air Liquide, Chevron, PetroChina and Keppel Infrastructure are planning to form a consortium that will explore the development of large-scale carbon capture, utilization and sequestration (CCUS) solutions and integrated infrastructure in Singapore.

Photo

Bachem Secures Major Peptide Contracts

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has announced the signing of two major contracts for supplying large volumes of peptides over the next two years. The orders are worth 25 million and 150 million Swiss francs for 2023 and 2024, respectively.

Photo

SABIC at K Show 2022

During this year’s K show, SABIC will highlight its commitment to circular, sustainable solutions designed to reduce plastic waste and support the shift to product electrification.

Photo

Syngenta and Bioceres Collaborate on Crops

Swiss-based and Chinese-owned agrochemicals company Syngenta has entered into a global commercial and R&D collaboration with Bioceres, a US-based provider of biological inoculants. Implementation of the agreement is subject to regulatory clearances.

Photo

Solvay Expands French Rare Earths Site

Solvay has announced plans to expand its rare earths operations in La Rochelle, France, in order to enter the permanent magnets sector in Europe and serve customers in the fast-growing electric vehicle, wind power and electronics markets.

Photo

Hempel Buys Cap Couleurs Store Network

Danish coatings company Hempel has acquired Cap Couleurs’ store network in southeastern France, maintaining its segment leadership in the Var region and supporting its growth initiatives. Financial terms were not disclosed.

Photo

Calum MacLean to Head Lanxess-Advent JV

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.

Photo

Koch and Ioniqa Partner on PET Recycling Technology

Koch Technology Solutions, the licensing arm of Koch Engineered Solutions, is partnering Ioniqa Technologies, a Dutch clean-tech spinoff from the Eindhoven University of Technology, to scale up and commercialize the latter’s advanced PET recycling process.

Photo

Henkel Buys NBD Nanotechnologies

Henkel has acquired US advanced materials start-up NBD Nanotechnologies for an undisclosed sum. Headquartered in Boston, Massachusetts, NBD specializes in developing coatings and additives with surface wettability.

Photo

Stepan Buys Surfactants from PerformanX

US specialty chemicals company Stepan has agreed to acquire the surfactant business and associated assets of compatriot firm PerformanX Specialty Chemicals. The purchase will include intellectual property, commercial relationships and inventory.

Photo

Global Amines Commissions Indonesia Plant

Singapore’s Global Amines – a joint venture between compatriot company Wilmar and Switzerland’s Clariant – has successfully started up a new fatty amines plant in Surabaya, Indonesia.

Photo

WuXi Opens Lipid Nanoparticle Facility

WuXi STA has opened a sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its campus in Wuxi city, China, in response to rising demand for complex injection dosage forms.

Photo

IMCD Buys Japan’s Kuni Chemical

IMCD has taken over Japanese specialty distribution company Kuni Chemical for an undisclosed sum. Kuni specializes in industrial applications that range from coatings and construction to automotive and packaging materials.

Photo

Hovione Expands Continuous Manufacturing Capabilities

Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers a commercial continuous tableting platform to support their key needs.

Photo

Germany’s Merck Expands French Facility

German science and technology company Merck has announced plans to invest more than €130 million at its site in Molsheim, France, to expand capacities for single-use assemblies, a key technology for producing Covid-19 vaccines and other therapies.

Photo

Novartis to Shutter a Sandoz US Plant

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US plants.

12185 more News

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.